Search the GHTC website

Global health R&D delivers for Maryland

US government investment in global health R&D has delivered

Amount
$2.5 billion
to Maryland research institutions
Jobs
30,700+ new jobs
for Maryland
Maryland's top USG-funded global health R&D institutions

Maryland's top USG-funded global health R&D institutions

National Institutes of Health (self-funding and other agency transfers)
$1.6 billion
Johns Hopkins University
$222.5 million
The Henry M. Jackson Foundation for the Advancement of Military Medicine
$221.9 million
U.S. Army Fort Detrick
$151.8 million
University of Maryland, Baltimore
$108.6 million
International Partnership for Microbicides
$44.7 million
Westat Inc.
$28.5 million
Walter Reed Army Institute of Research (including Military HIV Research Program)
$17.8 million
Technical Resources International, Inc.
$17.7 million
US Naval Medical Research Center
$13.9 million
University of Maryland, College Park
$12.8 million
Biomedical Research Institute
$11.6 million
US Uniformed Services University of Health Sciences
$2.6 million
Armed Forces Research Institute of Medical Sciences
$2.1 million
EMMES Corporation
$1.8 million
University of Maryland Biotechnology Institute
$1.8 million
Aeras
$1.6 million
US Army Medical Research Institute of Infectious Diseases
$1.5 million
US Army Medical Research and Materiel Command
$796 thousand
NOVA Research Company
$436 thousand
Towson University
$411 thousand
LTC Corporation
$381 thousand
US Food and Drug Administration
$298 thousand
Maryland industry in global health R&D

Maryland industry in global health R&D

Accelovance
Location(s): Rockville
AstraZeneca
Location(s): Frederick, Gaithersburg
Biological Mimetics
Location(s): Frederick
Celgene
Location(s): Odenton
Charles River Laboratories
Location(s): Frederick, Germantown
Eisai
Location(s): Baltimore
EMMES Corporation
Location(s): Frederick, Rockville
Fyodor Bio
Location(s): Baltimore
Genvec
Location(s): Gaithersburg
GSK
Location(s): Rockville
IDT Biologika
Location(s): Rockville
Leadiant Biosciences
Location(s): Gaithersburg
LTS Corporation
Location(s): Bethesda
NETE Solutions
Location(s): Rockville
NOVA Research Company
Location(s): Bethesda, Silver Spring
NovaVax
Location(s): Gaithersburg
Location(s): Bethesda
Prefectus BioSciences
Location(s): Baltimore
Protein Potential
Location(s): Rockville
Quigen
Location(s): Frederick, Germantown
Sanaria
Location(s): Rockville
Sequella Incorporated
Location(s): Rockville
Sisu Global Health
Location(s): Baltimore
SynPhaGen
Location(s): Gaithersburg
Technical Resources International
Location(s): Bethesda
Valneva
Location(s): Gaithersburg
Westat
Location(s): Rockville

Maryland's top areas of global health R&D by USG funding

60.6%
HIV/AIDS
14.9%
Tuberculosis
2.3%
Diarrheal diseases
9.3%
Neglected tropical diseases
Dengue
Helminths
Kinetoplastids
Leprosy
Trachoma
5.9%
Other
Bacterial pneumonia & meningitis
Cryptococcal meningitis
Ebola/viral hemorrhagic fevers
Salmonella infections
Rheumatic fever
Global health R&D at work in Maryland

The University of Maryland has developed a vaccine, Vaxchora™, to protect US adults traveling to cholera-affected areas. Vaxchora is the only cholera vaccine available in the United States, and the only single-dose vaccine for cholera licensed anywhere. Acquired through contaminated food or water, cholera can kill in less than 24 hours if left untreated. Widespread in 69 countries, this highly contagious disease impacts millions of people worldwide each year.

Footnotes
  • Methodology
  • USG global health R&D investment to state research institutions/Top USG-funded global health R&D institutions: Authors' analysis of USG investment data from the G-FINDER survey, including funding for R&D for neglected diseases from 2007–2015 and for Ebola and select viral hemorrhagic fevers from 2014–2015. Reflects USG funding received by entities in state including academic and research institutions, product development partnerships, other nonprofits, select corporations, and government research institutions, as well as self-funding or other federal agency transfers received by federal agencies located in state; but excludes pharmaceutical industry data which is aggregated and anonymized in the survey for confidentiality purposes. See methodology for additional details.
  • Jobs created: Based on previous analysis of the economic impact of National Institutes of Health R&D funding and author's analysis described above. See methodology for additional details.
  • Case study photo: Maryland GovPics/JayBaker